{"schema_version":"secwatch.filing_event.v1","accession":"0000882835-21-000057","form_type":"8-K","ticker":"ROP","cik":"0000882835","company_name":"ROPER TECHNOLOGIES INC","filed_at":"2021-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.976839+00:00","generated_at":"2026-06-28T18:59:01.822917+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Roper Q3 revenue up 22% to $1.46B; adjusted DEPS $3.91; announces three divestitures","bullets":["Continuing ops: revenue $1.46B (+22% GAAP, +12% organic); EBITDA $558M (+21%).","GAAP DEPS (incl. disc. ops) $2.71; adjusted DEPS $3.91; operating cash flow $447M.","Definitive agreements to divest TransCore, Zetec, and CIVCO Radiotherapy (now discontinued ops).","FY2021 continuing ops adjusted DEPS guidance $14.08-$14.12; Q4 adj DEPS $3.62-$3.66."],"urls":{"canonical":"https://secwatch.observer/filing/0000882835-21-000057","json":"https://secwatch.observer/filing/0000882835-21-000057.json","markdown":"https://secwatch.observer/filing/0000882835-21-000057.md","text":"https://secwatch.observer/filing/0000882835-21-000057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882835/000088283521000057/0000882835-21-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882835/000088283521000057/rop-20211022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T18:59:01.822917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}